El.En. S.p.A. · MIL:ELN

El.En — Star Conference 2015

36 slides from El.En's conference presentation, Mar 25, 2015

  1. Slide 1: Company Presentation FY 2014

    COMPANY PRESENTATION FY 2014 Star Conference – March 25th, 2015

  2. Slide 2: Disclaimer

    Disclaimer Certain statements in this slide show, including those addressing the Company’s beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic

  3. Slide 3: Summary

    Summary 1. LASERS AND LASER APPLICATIONS 2. THE GLOBAL LASER MARKET 3. EL.EN. GROUP 4. LASER SURGERY 5. 2014 FINANCIAL RESULTS 6. 2015 GUIDANCE 7. EL.EN. STOCK, MULTIPLES & COMPARABLES

  4. Slide 4: Lasers and Laser Applications

    Lasers and Laser Applications

  5. Slide 5: LASER

    LASER Light Amplification Stimulated by Emission of Radiation MEDICAL LASER Systems INDUSTRIAL LASER Systems

  6. Slide 6: The Global Laser Market

    aE. The Global Laser Market

  7. Slide 7: The Medical Laser Market

    The MEDICAL Laser Market Market CAGR 2013-2018 Market segment North Europe Asia Latin Total America America Energy Devices 6,9% 3,2% 15,3% 9,0% 7,8% Skin Rejuvenation 7,3% 5,8% 13,0% 11,8% 8,2% Body Contouring 11,3% 6,4% 18,3% 15,7% 12,4% Source: Medical Insight, Inc.

  8. Slide 8: The Industrial Laser Market

    The INDUSTRIAL Laser Market Global market and forecast for high power laser systems by application (by value) By Value Global Market (EUR Million) CAGR (%) 2013 2016 2020 2013-2016 2016-2020 Cutting 2.408 3.014 3.965 7,8 7,1 Welding and Brazing 1.249 1.605 2.231 8,7 8,6 Surface treatment and Other 5

  9. Slide 9: El.En. Group

    El.En. Group

  10. Slide 10: Group Overview

    Group Overview High –Tech laser photonics Group Develops, manufactures and distributes laser sources and laser systems for medical and industrial applications Know-how based on 30 years stratification of multidisciplinary experience FY 2014: Consolidated Revenues of €180 mln, up 14% YoY 951 employee

  11. Slide 11: El.En. Group

    &. El.En. Group

  12. Slide 12: Strategic Strengths

    Strategic Strengths Multidisciplinary and multifacility R&D activity: sources, systems, applications Industrial Combine High tech laser source development with flexible production facilities in high growth areas Medical Technological and clinical innovation improving performance and broadening the

  13. Slide 13: Consolidated Revenues and EBIT

    Consolidated Revenues and EBIT 180 25 EBIT 150 20 SALES 120 15 90 10 60 5 30 0 0 (5) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

  14. Slide 14: R&D Activity

    R&D Activity Clinical trials and validations of new therapeutic laser treatments and research on new applications of laser- tissue interaction Central role of PHOTOBIOLAB Extending Mona Lisa Touch Clinical studies Clinical studies on cutaneous ulcers New Pico second laser platform New dermatological

  15. Slide 15: Laser Surgery

    Laser Surgery Dr Paolo Salvadeo

  16. Slide 16: Consolidated Sales Volume

    Consolidated Sales Volume Euro ‘000 2013 : 11.759 2014 : 17.548 Increase : 49,23% Impact factors: • Urology and endo-urology • Vaginal Atrophy ( Mona Lisa Touch) • Strategic Agreements with major market players VIDEO

  17. Slide 17: 30 W Holmium lasers for Laser lithotripsy

    30 W Holmium lasers for Laser lithotripsy Worldwide market share 2012: 17% 2014: 34% Impact factors: • New strategic agreements • Strong regulatory committment worldwide (USA, Asia; next in line is Japan) • First Group in the world to have introduced the «dusting effect» avoiding retropulsion of sto

  18. Slide 18: Dusting Effect

    Dusting Effect Dusting Effect Conventional Lithotripsy Long Pulse Short Pulse

  19. Slide 19: 200 W Thulium Laser for BPH

    200 W Thulium Laser for BPH Worldwide market shares 2012: 8,7% 2014 : 12% Impact factors: • Introduction of the 200 W new Cyber platform • Goliath Study • Differentiation strategy • Safety, speed, reduced hospitalization and post op morbidities • Strong regulatory committment worldwide • Success on

  20. Slide 20: The Mona Lisa Touch

    The Mona Lisa Touch

  21. Slide 21: Strategic developments

    Strategic developments • Seeking regulatory (FDA) clearance for the combination of use of our lasers with the Da Vinci Robot (Intuitive Surgical – Nasdaq : ISRG) • (EU Horizon 2020) FOCAS Project • Developing new protocols for the «sub-mucosa laser dissection» (intestine + stomach real time endoscop

  22. Slide 22: Highlights

    Highlights Strategic Agreement with the San Donato Hospital Group, among the most significant groups of hospitals in the world, including San Raffaele from 2012. · DONATIONS BY QUANTA SYSTEM THULIUM LASER FOR POLICLINICO AGOSTINO GEMELLI IN MEMORY OF JOHN PAUL II, HOLMIUM LASER SPECIFIC TO THE CARE

  23. Slide 23: 2014 Financial Results

    2014 Financial Results Dr Enrico Romagnoli

  24. Slide 24: Consolidated P&L

    Consolidated P&L Euro/000 31/12/13 31/12/14 Var.% Revenues 157.380 100,0% 180.009 100,0% 14,4% Gross margin 74.563 47,4% 81.849 45,5% 9,8% EBITDA 13.741 8,7% 17.963 10,0% 30,7% EBIT (*) 9.582 6,1% 15.301 8,5% 59,7% Pretax Income (**) 10.694 6,8% 24.409 13,6% 128,2% Net income (**) 6.080 3,9% 16.520

  25. Slide 25: Consolidated BS

    Consolidated BS Euro/000 31/12/13 31/12/14 Var.% Total non current assets 72.976 61.775 -15% Net Working Capital 48.414 49.501 2% Net financial position 21.820 47.116 116% Long term liabilities 8.904 7.856 -12% Net Equity 134.306 150.536 12% Net capital employed 112.486 103.420 -8% Net Working Capit

  26. Slide 26: El.En. – Revenues breakdown by business

    El.En. – Revenues breakdown by business Euro /000 57.701 Industrial 48.017 Cutting Marking Laser sources Service 109.363 122.307 Medical Aesthetic Surgical Physiotherapy Dec. 31st, 2013 Dec. 31st, 2014 Dental Service 2014: +14%

  27. Slide 27: Medical Laser: Breakdown by Area

    Medical Laser: Breakdown by Area 35 30 25 20 Mln 15 10 5 0 Italy Europe North America Americas F/M East Japan 2013 2014

  28. Slide 28: Industrial Laser: Breakdown by Area

    Industrial Laser: Breakdown by Area 35 30 25 20 Mln 15 10 5 0 Italy Europe Americas Far East 2013 2014

  29. Slide 29: 2015 Guidance

    aE. 2015 Guidance

  30. Slide 30: 2015 forecast

    2015 forecast Sales: 200 mln +11% EBIT: % on Sales and amount to improve on 2014

  31. Slide 31: El.En. Stock, Multiples & Comparables

    El.En. Stock, Multiples & Comparables

  32. Slide 32: El.En. stock

    El.En. stock €. 6a. ——El.En. Group L L 2001 2002 2003 2004 2005 2006 (2007 2008 2009 2010 2011 2012 2013 2014

  33. Slide 33: El.En. multiples

    El.En. multiples Stockholder's Equity per share * 31 Price / Book Value Adj. 1,24 EV /EBIT (85% EBIT) 8,35 EV / Sales (85% Sales) 0,71 El.En. Market Cap. 183,9 @ €38,12 Net financial position 47,1 @ 31/12/14 Market value of 1,0 mm Cynosure shares 28,2 @ $30 (Euro/Usd=1,0624) Enterprise Value 109 Sto

  34. Slide 34: El.En. Comparables

    El.En. Comparables Price Revenue Var.% EBIT EBIT % MK.Cap. EV EV/Sales EV/EBIT P/Book Dec. 31, 2014 Revenue Value Medical/Aesthetic Syneron $12,03 $255.750 0% $(2.217) -1% $433.070 $339.412 1,33 n.a. 1,90 Zeltiq $33,62 $174.480 56% $2.120 1% $1.280.000 $1.235.440 7,08 582,75 18,15 Lumenis $11,71 $28

  35. Slide 35: Investor Relations Contacts

    El.En. SPA Enrico ROMAGNOLI Investor Relations Manager tel. +39 055-8826807 E-mail: finance@elen.it POLYTEMS HIR SRL Bianca FERSINI MASTELLONI Financial Communication Tel. +39 06-6797849 / +39 06-69923324 E-mail: b.fersini@polytemshir.it POLYTEMS HIR SRL Veronica ADRIANI Press office Tel. +39 06-679

  36. Slide 36: Medical & Industrial

    Medical & Industrial

El.En. — Star Conference 2015 on 6ix